Ouch. A seemingly good idea shot the whole talent pipeline in the foot, leaving a huge gap in the team that actually *reads* the new drug applications. 🤯 Seems like groundbreaking policy changes mean absolutely nothing if the reviewers on the front lines aren't onboard with accepting modern testing like 'cells on a chip.' Innovation stops where the paperwork meets the desk. Big question: How do you bridge that gap between HQ vision and ground-level execution? 👀 #FDA #DrugReview #MedTech #WorkplaceFail #InnovationStall - @dansfera